Phenoxybenzamine Hydrochloride
- Product NDC
- 49884-038
- 11-digit product format
- 498840038
- Labeler code
- 49884
- Product ID
- 49884-038_18957b76-0baa-495e-8917-03b6fc16d065
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Phenoxybenzamine Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Par Pharmaceutical, Inc.
- Application
- ANDA204522
- Marketing category
- ANDA
- Marketing start
- 2017-01-24
- Marketing end
- 0000-00-00
- Substance
- PHENOXYBENZAMINE HYDROCHLORIDE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status.
Dataset, Scope, Product NDC table| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|
| excluded product | product | 49884-038 | | D | Discontinued by firm | | 2026-07-31 |
| excluded package | package | 49884-038 | 49884-038-01 | D | Discontinued by firm | | 2026-07-31 |
Orange Book products#
Application-product, Trade name, Ingredient table| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|
| A204522-001 | PHENOXYBENZAMINE HYDROCHLORIDE | PHENOXYBENZAMINE HYDROCHLORIDE | 10MG | CAPSULE / ORAL | AB | RS | 2017-01-24 |
Therapeutic equivalence codes#
Application-product, TE code table| Application-product | TE code |
|---|
| A204522-001 | AB |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 49884-038-01 | 49884003801 | 100 CAPSULE in 1 BOTTLE (49884-038-01) | 100 capsule | 2017-01-24 | 0000-00-00 | No | No | Current |